Nexos

Exolvo Biosciences

Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.

Exolvo

This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.

Theraport

Theraport develops engineered exosomes to facilitate the targeted delivery of drugs and genetic medicines for patients with complex diseases.

Emulsi Biotech

Emulsi Biotech develops lipid-based oral drug delivery platforms to enable pharmaceutical companies to administer complex biological therapies through capsules instead of injections.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Nexosome Oncology

The company develops exosome-based blood tests for early-stage cancer detection and provides biomarker discovery services for pharmaceutical and biotechnology organisations.

Biograil

This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.

I2 Therapeutics

This company develops oral drug delivery formulations and long-acting therapies for metabolic and inflammatory diseases to improve patient adherence and treatment efficacy.